Skip to main content
Skip to primary sidebar
Skip to footer
Tepmetko is the new FDA approved Only Once-daily oral drug for Aggressive Metastatic NSCLC patients
New FDA approved Cabenuva treatment regiment for HIV-1 Patients
FDA approved the supplemental new drug application for Xalkori for pediatric ALCL patients
FDA New Drug Therapies Approval 2015 – Present
53 New Drug Therapy Approvals by the FDA in 2020
Holistic Forecasting Model is Need of the Hour
Checkout out our latest research here
Privacy and Terms
Copyright © 2020 – 2021 Fore Pharma.
All rights reserved.